Trial Profile
Interventional, Open-label, Positron Emission Tomography (PET) Study Investigating D2 Dopamine Receptor Occupancy After Oral Dosing of Lu AF35700 in Healthy Men Using [11C]-PHNO as Tracer Compound
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2014
Price :
$35
*
At a glance
- Drugs LU AF-35700 (Primary)
- Indications Unspecified
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Lundbeck A/S
- 26 Sep 2014 Status changed from recruiting to completed.
- 19 May 2014 New trial record